Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder. FRAMINGHAM, MA / ACCESS Newswire / November 4, 2025 / Ignite Biomedical, Inc. (" ...
Thomas Jefferson University and Sempresto, Inc. are pleased to announce an exclusive licensing agreement for a novel epinephrine autoinjector designed to improve accessibility and ease of use for ...
Karus Mining Inc. announces the appointment of a new Chief Executive Officer . Effective 3, 2025, Mr. Jason Bahnsen assumed the role of CEO of Karus. Alex Gostevskikh has resigned as Interim CEO to ...